Enliven Therapeutics, Inc. (NASDAQ:ELVN – Get Free Report) was the recipient of a significant increase in short interest during the month of April. As of April 15th, there was short interest totalling 4,640,000 shares, an increase of 9.7% from the March 31st total of 4,230,000 shares. Based on an average trading volume of 247,800 shares, […]
Shares of Enliven Therapeutics, Inc. (NASDAQ:ELVN – Get Free Report) were down 3.9% during trading on Monday after an insider sold shares in the company. The company traded as low as $18.64 and last traded at $18.64. Approximately 9,380 shares traded hands during trading, a decline of 94% from the average daily volume of 144,773 […]
Enliven Therapeutics, Inc. (NASDAQ:ELVN – Get Free Report) Director Rahul D. Ballal sold 3,237 shares of Enliven Therapeutics stock in a transaction that occurred on Monday, April 1st. The shares were sold at an average price of $19.08, for a total transaction of $61,761.96. Following the transaction, the director now directly owns 22,341 shares of […]
Enliven Therapeutics, Inc. (NASDAQ:ELVN – Get Free Report) Director Rahul D. Ballal sold 3,237 shares of the stock in a transaction that occurred on Monday, April 1st. The shares were sold at an average price of $19.08, for a total transaction of $61,761.96. Following the completion of the transaction, the director now owns 22,341 shares […]
Rahul D. Ballal Sells 3,237 Shares of Enliven Therapeutics, Inc. (NASDAQ:ELVN) Stock themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.